Biotrend Cevre Ve Stock Current Asset
BIOEN Stock | TRY 17.85 0.15 0.85% |
Biotrend Cevre ve fundamentals help investors to digest information that contributes to Biotrend Cevre's financial success or failures. It also enables traders to predict the movement of Biotrend Stock. The fundamental analysis module provides a way to measure Biotrend Cevre's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotrend Cevre stock.
Biotrend |
Biotrend Cevre ve Company Current Asset Analysis
Biotrend Cevre's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition |
In accordance with the recently published financial statements, Biotrend Cevre ve has a Current Asset of 0.0. This is 100.0% lower than that of the Utilities sector and about the same as Utilities—Renewable (which currently averages 0.0) industry. The current asset for all Turkey stocks is 100.0% higher than that of the company.
Biotrend Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotrend Cevre's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotrend Cevre could also be used in its relative valuation, which is a method of valuing Biotrend Cevre by comparing valuation metrics of similar companies.Biotrend Cevre is currently under evaluation in current asset category among its peers.
Biotrend Fundamentals
Return On Equity | 0.0978 | |||
Return On Asset | 0.0657 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.22 % | |||
Shares Owned By Insiders | 67.23 % | |||
Shares Owned By Institutions | 1.80 % | |||
Price To Earning | 114.34 X | |||
Revenue | 427.7 M | |||
Gross Profit | 123.34 M | |||
EBITDA | 84.88 M | |||
Net Income | 3.79 M | |||
Cash And Equivalents | 25.91 M | |||
Cash Per Share | 0.20 X | |||
Total Debt | 696.56 M | |||
Debt To Equity | 2.09 % | |||
Current Ratio | 0.77 X | |||
Book Value Per Share | 0.98 X | |||
Cash Flow From Operations | (326.18 M) | |||
Earnings Per Share | 0.01 X | |||
Target Price | 13.1 | |||
Number Of Employees | 529 | |||
Total Asset | 1.83 B | |||
Net Asset | 1.83 B |
About Biotrend Cevre Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotrend Cevre ve's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotrend Cevre using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotrend Cevre ve based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biotrend Stock
Biotrend Cevre financial ratios help investors to determine whether Biotrend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotrend with respect to the benefits of owning Biotrend Cevre security.